Research finds people diagnosed with HIV in New York State were more than twice as likely to die from COVID-19

University at Albany, State University of New York

Newswise — ALBANY, N.Y. (Feb 3, 2021) – New research out of the University at Albany School of Public Health and the AIDS Institute at the New York State Department of Health examined the relationship between HIV infection and COVID-19 – finding that through the middle of 2020, people diagnosed with HIV infection were significantly more likely to contract, be hospitalized with and die from COVID-19.

More than one million people in the U.S. are diagnosed with HIV, with more than 100,000 living in New York State. According to Eli Rosenberg, associate professor of Epidemiology and Biostatistics, because HIV infection weakens the immune system and is associated with a variety of comorbidities, people living with HIV may be more vulnerable to COVID-19.

Published in JAMA Network Open, the researchers from both institutions merged statewide databases for HIV surveillance, COVID-19 diagnoses and COVID-19 hospitalizations. They then compared rates of COVID-19 diagnosis, hospitalization and death between New Yorkers with and without an HIV diagnosis from March to mid-June. Because some increased mortality is a result of people with HIV having risk factors for COVID-19 (such as being male and older), the researchers also conducted an adjusted analysis to understand “how much was due to HIV infection itself,” Rosenberg said.

Results before adjustment include:

  • New Yorkers with an HIV diagnosis were 43 percent more likely to be diagnosed with COVID-19 than those without HIV, and 161 percent more likely to be hospitalized with the virus
  • HIV patients diagnosed with COVID-19 were 155 percent more likely to die in the hospital of COVID-19 than those without HIV
  • One in 522 New Yorkers infected with HIV died in the hospital of COVID-19 from March to mid-June
  • Those with more advanced HIV disease (in terms of lower CD4+ T-cell levels, a type of white blood cell typically used as a marker for HIV) faced even greater risks from COVID-19

After adjustment, results indicated that the levels of diagnosis and mortality, given a person was already hospitalized, were not driving disparities in total hospitalizations and deaths. Rather, it was the likelihood of developing severe COVID-19 needing hospitalization, once infected, which appeared to explain elevated levels of hospitalization and death – persons with HIV still had 1.38 times (or 38 percent more) the level of hospitalization compared to those without.   

“New York has long been an epicenter of the HIV epidemic and in the spring became the epicenter of the COVID-19 pandemic,” said Rosenberg. “Data from New York offer an unparalleled opportunity to understand the intersection of the epidemic.”

“The results indicate that prevention and treatment efforts need to give additional consideration and support to the needs and heightened risk of persons living with HIV, including vaccination efforts, when the federal government makes more doses available.” concluded Rosenberg.

Noting that current CDC recommendations are inconclusive about whether HIV infection is considered a qualifying underlying illness for vaccine prioritization, David Holtgrave, dean of the School of Public Health and a researcher on the project, added, “We must ensure that all persons living with HIV are appropriately prioritized and are supported to access safe and highly-efficacious COVID-19 vaccines as soon as supplies become available.”

“As our results clearly establish that more advanced HIV disease is associated with worse COVID-19 outcomes, it is critically important that as soon as additional doses become available from the federal government, people living with HIV have access to and accept vaccination,” said Johanne Morne, Director of the AIDS Institute and study author. “This, along with continued medication adherence and access to HIV care, could help to mitigate the impact of COVID and ensure that the significant progress realized over the last several years towards ending New York State’s HIV epidemic is not lost.”

Citing the evidence of this study, the AIDS Institute’s HIV Clinical Guidelines Committee recently issued a statement outlining the case and recommended practices for vaccination of persons living with HIV.

The study is part of the Center for Collaborative HIV Research in Practice and Policy at the School of Public Health, a research center designed to leverage partnerships with the AIDS Institute and other collaborators to expand collaborations to address social justice and public health challenges of persons at risk for or living with HIV and related diseases.

###

SEE ORIGINAL STUDY



Filters close

Showing results

110 of 5849
Newswise:Video Embedded newswise-expert-panels-on-covid-19-pandemic-notable-excerpts-quotes-and-videos-available
VIDEO
Released: 18-Jun-2021 2:10 PM EDT
Newswise Expert Panels on COVID-19 Pandemic: Notable excerpts, quotes and videos available
Newswise

Newswise is hosting a series of Expert Panels discussion on unique aspects of the COVID-19 pandemic. This tip sheet includes some notable quotes from the panelists.

access_time Embargo lifts in 2 days
Embargo will expire: 23-Jun-2021 8:00 AM EDT Released to reporters: 18-Jun-2021 11:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Jun-2021 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise:Video Embedded virtual-event-for-june-17-11am-edt-covid-19-vaccines-and-male-fertility
VIDEO
Released: 18-Jun-2021 8:55 AM EDT
VIDEO AND TRANSCRIPT AVAILABLE: Vaccines and Male Fertility Event for June 17, 2021
Newswise

This upcoming JAMA-published study examined whether the COVID-19 vaccine impacts male fertility.

access_time Embargo lifts in 2 days
Embargo will expire: 22-Jun-2021 11:00 AM EDT Released to reporters: 18-Jun-2021 8:30 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 22-Jun-2021 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 18-Jun-2021 7:05 AM EDT
Teamwork saves lives: COVID-19 hospital network shares key findings to improve care
Michigan Medicine - University of Michigan

Data sharing among 40 Michigan hospitals about the care and outcomes for thousands of inpatients with COVID-19 has led to reduced variation and findings that could inform care anywhere, including approaches for preventing blood clots and reducing overuse of antibiotics, as well as a risk prediction tool.

Released: 18-Jun-2021 7:05 AM EDT
One-third of older Americans delayed health care over COVID concerns
Michigan Medicine - University of Michigan

Nearly one in three Americans between the ages of 50 and 80 put off an in-person appointment for medical care in 2020 because they were worried about exposure to the novel coronavirus, new national poll data show.

Released: 17-Jun-2021 4:15 PM EDT
UNC Researchers Lead Study of Diabetes Treatment of COVID-19 Patients
University of North Carolina School of Medicine

Diabetes is one of the comorbidities most strongly associated with severe COVID-19 in the US, and data from early in the pandemic suggested individuals with type 2 diabetes faced twice the risk of death from COVID-19 and a greater risk of requiring hospitalization and intensive care. A new study shows best treatment options.

Released: 17-Jun-2021 4:10 PM EDT
Vaccination, Previous Infection, Protect Against COVID-19 gamma/P.1 Variant in Animal Model
University of Wisconsin-Madison

In a new study using variant virus recovered from one of the original travelers, researchers in the U.S. and Japan have found that vaccination with an mRNA vaccine induces antibody responses that would protect humans from infection with the gamma/P.1 variant.

Released: 17-Jun-2021 1:30 PM EDT
Hackensack Meridian Doctors, Student Help Establish Way to Prioritize Surgeries During COVID-19 lockdown
Hackensack Meridian Health

The MeNTS method of prioritizing surgeries during the height of pandemic, developed by University of Chicago, helped procedures continue during time of need

Released: 17-Jun-2021 12:55 PM EDT
‘Nanodecoy’ Therapy Binds and Neutralizes SARS-CoV-2 Virus
North Carolina State University

Nanodecoys made from human lung spheroid cells (LSCs) can bind to and neutralize SARS-CoV-2, promoting viral clearance and reducing lung injury in a macaque model of COVID-19.


Showing results

110 of 5849

close
1.40903